This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient is beginning to take a combination estrogen-progestin product as an oral contraceptive ... (Read 178 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
on: Jul 23, 2018
A patient is beginning to take a combination estrogen-progestin product as an oral contraceptive (OC). Which symptom(s), if verbalized, demonstrates that the patient has knowledge of the ad-verse effects associated with this drug?
 
  a. Total loss of menses
  b. Reduced breast size
  c. Hypotension
  d. Hypertension

Question 2

A patient who is receiving anticoagulant therapy is also being started on estrogen therapy. Which action may the health care provider need to take because of the interaction of these drugs?
 
  a. Increase the dose of the anticoagulant.
  b. Decrease the dose of the anticoagulant.
  c. Increase the dose of estrogen.
  d. Add ascorbic acid to the therapy.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leahm14

  • Sr. Member
  • ****
  • Posts: 322
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: D
The estrogenic adverse effects from OCs include nausea, vomiting, breast tenderness and en-largement, hypertension and migraine headaches. Progestins can cause appetite increase, weight gain, fatigue, depression, and decreased libido.

Answer to Question 2

ANS: A
The action of clotting factors is increased by estrogen, thus diminishing the effects of oral anti-coagulants. Thus the anticoagulant dose may have to be increased.


scienceeasy

  • Hero Member
  • *****
  • Posts: 565
Reply #2 on: Jul 23, 2018
TY


leahm14

  • Sr. Member
  • ****
  • Posts: 322
Reply #3 on: Jul 23, 2018
You're welcome


« previous next »
 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Documenting the health history is a crucial step in providing patient care Documenting the health history is a crucial step in providing patient care
Defibrillator. Defibrillators are devices that supply a voltage charge to the heart in the hope of r Defibrillator. Defibrillators are devices that supply a voltage charge to the heart in the hope of r
Patient teaching: vascular assessment Patient teaching: vascular assessment
Medical assistants can quickly pull up a patient record when a phone call is received. Medical assistants can quickly pull up a patient record when a phone call is received.
The direct product of phosphate hydrolysis from PEP is the enol form of pyruvate The direct product of phosphate hydrolysis from PEP is the enol form of pyruvate
Video: Sperm Formation

For a complete list of videos, visit our video library